Kohta Takei

Kohta Takei

Auto-generated profile, based on publicly available information

Kohta Takei

Nagano Children’s Hospital

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
KIKei Inai
Kei Inai
RIRyo Inuzuka
Ryo Inuzuka
HOHiroshi Ono
Hiroshi Ono
MNMasaki Nii
Masaki Nii
SOShinichi Ohtsuki
Shinichi Ohtsuki
Toshio NakanishiToshio Nakanishi
Toshio Nakanishi
Aims: The criteria for ‘good’ Fontan haemodynamics have been poorly defined in relation to long-term outcomes. The aim of this study was to identify the risk factors for mortality among haemodynamic parameters obtained early after the Fontan operation. Methods and results: Clinical data of all perioperative survivors of the Fontan operation performed before 2011, from nine institutions, were collected through a retrospective chart review. In total, 1260 patients were included. The median age at the time of Fontan operation was 3.6 years. Post-operative cardiac catheterization was conducted in 1117 patients at a median period of 1.0 years after the operation. During the median follow-up period of 10.2 years, 107 patients died. The mortality rates at 10, 20, and 25 years after the operation were 5%, 12%, and 22%, respectively. On multivariable analysis, older age at the time of the operation {≥15 years, hazard ratio (HR) [95% confidence interval (CI)]: 3.2 (1.7–5.9)} and haemodynamic parameters obtained at post-operative catheterization, such as low ejection fraction [<30%, HR (95% CI): 7.5 (3.2–18)], low systemic oxygen saturation [<80%, HR (95% CI): 3.8 (1.6–9.1)], high central venous pressure [≥16 mmHg, HR (95% CI): 2.3 (1.3–3.9)], and low mean systemic arterial pressure [<60 mmHg, HR (95% CI): 3.0 (1.4–6.2)] were identified as independent predictors of mortality. The predictive model based on these parameters had a c-index of 0.75 at 10 years. Conclusions: Haemodynamic parameters obtained at a median period of 1.0 years, post-operatively, can accurately identify patients with a high mortality risk, who may need intensive management to improve long-term outcomes.

21 December 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
MNMasaki Nii
Masaki Nii
RIRyo Inuzuka
Ryo Inuzuka
KIKei Inai
Kei Inai
ESEriko Shimada
Eriko Shimada
TSTokuko Shinohara
Tokuko Shinohara
Toshio NakanishiToshio Nakanishi
Toshio Nakanishi

16 December 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
HOHideo Ohuchi
Hideo Ohuchi
KTKohta Takei
Kohta Takei
JMJun Muneuchi
Jun Muneuchi
SKShingo Kasahara
Shingo Kasahara
YIYuichi Ishikawa
Yuichi Ishikawa
MNMichikazu Nakai
Michikazu Nakai
Background: Management strategies of unplanned hospitalizations (UPH) vary and have not been well characterized in patients with Fontan circulation. Methods: We prospectively followed 3226 Fontan patients for 3 years to characterize the current UPH status and elucidate the associations between in‐hospital management strategies and postdischarge outcomes. Results: A total of 243 UPHs occurred (2.5 cases/100 person‐years). Fontan‐related UPHs accounted for 154 cases (63%), most commonly due to heart failure (19%), protein‐losing enteropathy (16%), hemorrhage (14%), arrhythmia (9%), thromboembolism (3%), and plastic bronchitis (2%). Fontan‐unrelated UPHs (89 cases; 37%) were mainly due to infections (19%). Adult patients were more frequently hospitalized for hemorrhage and thromboembolism ( P <0.05). The longest length of hospital stay was observed in protein‐losing enteropathy, followed by thromboembolism and heart failure. Among nonpharmacological treatments, oxygen therapy was commonly used, followed by surgical procedures and catheter‐based interventions. Among pharmacological treatments, diuretics were commonly administered, followed by heparin and catecholamines. Of 240 patients discharged alive, 76 (15.4 cases/100 person‐years) were readmitted. Protein‐losing enteropathy was the most frequent cause of readmission, followed by heart failure and hemorrhage. In addition to conventional risk factors, in‐hospital management practices, such as oxygen therapy, surgical intervention, and diuretic adjustment were associated with readmission risk ( P <0.01–0.001). Conclusions: We clarified real‐world practices related to UPHs in Fontan patients. Specific in‐hospital treatment strategies were associated with the risk of readmission. Further studies are warranted to determine the causal relationships between treatment approaches and outcomes for standardized management strategies.

30 September 2015 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
RYRyutaro Yamada
Ryutaro Yamada
KTKohta Takei
Kohta Takei
YKYosuke Kaneshi
Yosuke Kaneshi
MMMamoru Morikawa
Mamoru Morikawa
KCKazutoshi Cho
Kazutoshi Cho
HMHisanori Minakami
Hisanori Minakami
In a fetus with suspected heterotaxy syndrome, a decreased/absent baseline variability of fetal heart rate pattern developed at gestational week 36+5 and continued for 5 days until birth at gestational week 37+2, while repeat biophysical profile scorings with ultrasound were consistently unremarkable. This neonate weighing 2404 g with Apgar scores of 7 (1‐min) and 8 (5‐min) and umbilical arterial cord blood pH of 7.28 with base deficit of 3.9 mmol/L, showed a heart rate of 120 b.p.m. for 3 h after birth, but subsequently developed sinus bradycardia (84 b.p.m.) unresponsive to crying. Isoproterenol initiated 9 h after birth was effective in the increase of heart rate to 120 b.p.m. in this neonate. Brain magnetic resonance imaging at 16 days of age was unremarkable. The decreased/absent baseline variability of fetal heart rate pattern was speculated to have been caused by sinus node dysfunction, and not by reduced fetal oxygenation in this case.

3 November 2015 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
KTKohta Takei
Kohta Takei
MMMamoru Morikawa
Mamoru Morikawa
KCKazutoshi Cho
Kazutoshi Cho
HMHisanori Minakami
Hisanori Minakami
A case of hydrops fetalis (HF) that resolved after corticosteroid therapy despite persisting fetal tachycardia of 190 bpm is reported. The fetus with confirmed normal karyotype had HF in the presence of atrial flutter and sustained ventricular rate of 200–210 bpm at gestational week (GW) 31–6/7. Aetiologies of HF other than fetal tachyarrhythmia were unlikely in this infant. The patient's family declined pharmacological treatment with maternal digoxin and desired to continue pregnancy with only intensive monitoring of fetal condition. Maternal transplacental β-methasone was given to facilitate fetal lung maturation. The fetal tachyarrhythmia ameliorated to 190 bpm at GW 32–5/7and HF gradually disappeared by birth. The otherwise healthy female neonate weighing 3050 g born at GW 37–0/7was successfully treated with cardioversion performed 60 min after birth. This case suggested that corticosteroid therapy contributed to the resolution of HF associated with tachyarrhythmia.

28 February 2025 in Pediatric Cardiology and Cardiac Surgery
Verified
Journal Article
Open access
PDF file
KTKohta Takei
Kohta Takei
胎児心エコーによる胎児心疾患の出生前診断は,これまで形態診断を中心に行われてきたが,近年胎児の心機能評価についての知見も集積されてきており,国内外のガイドラインでも胎児心機能評価についての記載がなされている.一方で,胎児の心機能評価においては,出生後とは異なる胎児循環であること,小さい胎児を母体の腹壁を通して観察しなくてはならず超音波診断装置が進歩した現在でも画質に限界があること,胎位が一定ではなく常に一定の断面が得られるわけではないこと,心電図が利用できないことなどの制約あり,必ずしも出生後と同様の方法を用いて評価することができるわけではない.本稿では,現在胎児心エコーにおいて用いられている胎児心機能評価法について,中心静脈圧上昇の評価,心室収縮機能評価,心室拡張機能評価,心室の統合機能評価,胎児心不全の予後評価,新しい技術を使用した心機能評価の各項目に分けて,簡単な原理もふまえて概説する.